Eclipse Therapeutics Garners $2,775,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e91012e4-7a5c-44c1-97f5-6e7ceacd033d&Preview=1 -
Date
10/17/2011 -
Company Name
Eclipse Therapeutics -
Mailing Address
Undisclosed San Diego , CA 92102 -
Company Description
Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. -
Website
http://www.eclipsetherapeutics.com -
Transaction Type
Debt -
Transaction Amount
$2,775,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
